Seasoned investor and operator focused on growth-stage technology and healthcare companies, with a background in corporate finance and operational leadership. David W. Sommer brings experience in strategic M&A, board advisory and capital formation, often supporting scaling, governance and exit planning. Known for hands-on portfolio management and cross-border deal experience, offers network access to growth capital, strategic buyers and executive talent in later-stage private markets.
Seasoned investor and operator focused on growth-stage technology and healthcare companies, with a background in corporate finance and operational leadership. David W. Sommer brings experience in strategic M&A, board advisory and capital formation, often supporting scaling, governance and exit planning. Known for hands-on portfolio management and cross-border deal experience, offers network access to growth capital, strategic buyers and executive talent in later-stage private markets.
Focuses on growth-stage technology and healthcare opportunities where operational engagement accelerates scale and exit optionality. Prefers businesses with durable unit economics, scalable go-to-market and regulatory or clinical moats, deploying staged, milestone‑linked capital and retaining follow-on reserves. Investment decisions blend corporate‑finance discipline with operator-led value creation: active board involvement, strategic M&A readiness, governance upgrades and recruitment of executive talent. Uses cross‑border networks to source strategic co-investors and buyers, targets multi‑year value realization while monitoring KPIs to control downside.
Focuses on growth-stage technology and healthcare opportunities where operational engagement accelerates scale and exit optionality. Prefers businesses with durable unit economics, scalable go-to-market and regulatory or clinical moats, deploying staged, milestone‑linked capital and retaining follow-on reserves. Investment decisions blend corporate‑finance discipline with operator-led value creation: active board involvement, strategic M&A readiness, governance upgrades and recruitment of executive talent. Uses cross‑border networks to source strategic co-investors and buyers, targets multi‑year value realization while monitoring KPIs to control downside.
| Trades 879 | Longs Won 655/879 74% | Profit Factor 16.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.28M |
| Average Win $269,142.78 | Best Trade (Jul 13) $34.37M | Sharpe Ratio -12.17 |
| Average Loss -$46,445 | Worst Trade (Dec 31) -$934,786.01 | Z-Score 13.22 (100%) |
| Commissions $0 | Avg. Trade Length 2y 3m 3w 4d | Expectancy $188,719.96 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 8,403 | 7,563 | 6,723 | 5,882 | 5,042 | 4,202 | 3,361 | 2,521 | 1,681 | 840 |